InvestorsHub Logo
Followers 1521
Posts 89033
Boards Moderated 4
Alias Born 05/09/2004

Re: floridaboy post# 3625

Monday, 05/17/2021 12:59:44 PM

Monday, May 17, 2021 12:59:44 PM

Post# of 13742
"The registration enables Escozine® to be prescribed as a natural bioactive alternative medicine to be used in cancer treatments as well as a treatment for the SARS-CoV-2 (COVID-19) virus, after Medolife performed a safety and efficacy study on COVID-19. This registration in the DR through in-place trade agreements opens the door for distribution and sales in most of Latin America."
https://www.globenewswire.com/news-release/2021/05/04/2222245/0/en/Medolife-Rx-Announces-Historic-Product-Registration-in-Dominican-Republic-Enabling-Escozine-to-Be-Sold-Throughout-Latin-America-as-Natural-Alternative-Cancer-Medicine.html

"As of March 2, 2020, population of Latin America and the Caribbean was estimated at more than 652 million"
https://en.wikipedia.org/wiki/Latin_America

and that is after this

"Medolife Rx (Quanta, Inc.) Reports Over $1 Million in Revenue in 2020 Year-End Filing, Comments on Operations"
https://www.otcmarkets.com/stock/QNTA/news/story?e&id=1867919

and there is still this to add into the mix
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=163834276

Regardless of FDA approval this will still be making big moves due to even bigger sales in the future. Imo

http://medolife.com/order

https://quantrx.com/shop
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.